Andaleb Kholmukhamedov/LinkedIn
Oct 4, 2025, 12:38
Andaleb Kholmukhamedov: Anticoagulation Management: Current Landscape And Future Trends
Andaleb Kholmukhamedov, Head of Hemostasis Assay Development at Werfen North America, posted on LinkedIn:
”Latest publication in the MDPI Journal of Clinical Medicine’s Special Issue on Advances in Thrombosis and Haemostasis
Our paper provides a comprehensive review of the current and future landscape of Anticoagulation Therapy – a critical field balancing life-saving clot prevention with bleeding risk.”
Read the full article here.
Title: Anticoagulation Management: Current Landscape and Future Trends
Authors: Andaleb Kholmukhamedov, David Subbotin, Anna Gorin, Ruslan Ilyassov
Stay updated with Hemostasis Today.
Andaleb Kholmukhamedov
Anna Gorin
Anticoagulation
Anticoagulation Management
Anticoagulation Therapy
Bleeding Risk
Blood Clot
David Subbotin
Health
Hematology
Hemostais
Hemostais Today
MDPI Journal
Medicine
Ruslan Ilyassov
San Diego State University
Scripps Memorial Hospital
thrombosis
University of California Los Angeles
Versiti Blood Research Institute
Werfen North America
-
Dec 15, 2025, 15:58Khaled Musallam Applauds Hatoon Ezzat’s Leadership and Healthcare Advances in Saudi Arabia
-
Dec 15, 2025, 12:46Deborah Ebert Long on Hemophilia Care: Progress, Possibility, and the Power of Listening
-
Dec 15, 2025, 12:34Nathan Connell on Conversion from Eptacog Alfa to Beta
-
Dec 15, 2025, 12:17Danny Hsu on Interdisciplinary Toolkit for Gynecologic Bleeding on Anticoagulation
-
Dec 15, 2025, 12:08Ted Roh: A Historic Milestone for Indonesia’s Health Innovation
-
Dec 15, 2025, 11:28Wolfgang Miesbach Shares Insights from Davide Matino’s Presentation on Marstacimab at ASH25
-
Dec 15, 2025, 11:12Tushar Pandey Awarded for His Enourmous Contribution to Hematology
-
Dec 15, 2025, 11:07DISTRO: Vidya Rajbhoj on AI and Digital Technology to Improve Stroke Rehabilitation
-
Dec 15, 2025, 11:00Ischemic Stroke, AF and Atherosclerotis: Amira Khater on Sufficiency of Anticoagulant Monotherapy